DEF 14A: ProAssurance Sets Date for 2025 Annual Stockholders Meeting Amidst Merger Agreement Discussions

ProAssurance Corporation announces its annual stockholders meeting to be held on May 21, 2025, to elect directors, ratify the appointment of auditors, and conduct an advisory vote on executive compensation, while a separate special meeting will address the proposed acquisition by The Doctors Company.

Summary

• ProAssurance Corporation will hold its Annual Meeting of Stockholders on May 21, 2025, at 9:00 a.m. Central Daylight Time, at its headquarters in Birmingham, Alabama.
• The meeting will address the election of three Class III directors, ratification of Ernst & Young LLP as independent auditors, and an advisory vote on executive compensation.
• The Board of Directors set March 24, 2025, as the record date for the annual meeting.
• The proxy statement does not address the proposed acquisition of ProAssurance by The Doctors Company, which will be voted on at a separate special meeting.
• As of the record date, there were 63,676,761 issued shares of Common Stock, with 12,606,968 shares held as treasury shares that cannot be voted.
• A quorum requires the presence of holders of one-third of the shares of Common Stock entitled to vote.
• The Board of Directors recommends voting FOR the election of director nominees, FOR the ratification of Ernst & Young LLP, and FOR the approval of executive compensation.
• The Board intends to reduce the size of the Board from the current ten directors to nine and equalize the sizes of the classes by reclassifying Mr. Di Piazza as a Class III director.
• Kedrick D. Adkins, C.P.A., a member of the Company’s current Class III of directors, has served on the board since 2018 and is not standing for re-election at the 2025 annual meeting because he has reached the maximum age described in our By-Laws and Corporate Governance Principles.

Sentiment

Score: 7

Explanation: The document presents a mixed sentiment. While there are improvements in key financial metrics like Non-GAAP operating income and combined ratio, there are also underwriting losses in specific segments and no payouts for performance-based equity awards. The overall tone is cautiously optimistic, focusing on strategic initiatives and long-term growth.

Positives

• The consolidated combined ratio improved to 109.4% and drove Non-GAAP operating income of $48.6 million.
• Net investment income increased 11.7% to over $141 million, and book value per share rose 7.7% to $23.49.
• Full-year net income reached $52.7 million, or $1.03 per diluted share, and Non-GAAP operating income was $48.6 million, or $0.95 per diluted share.
• The management team continued their focus on our long-term strategic initiatives which are focused on continued improvement in our Non-GAAP operating earnings.
• Annual incentives paid to our Named Executive Officers ranged from 134.0% to 200.0% of the target level.

Negatives

• Performance-based equity awards that matured in 2024 resulted in no payouts.
• For 2024, we reported Non-GAAP operating income of $48.6 million , or $0.95 per diluted share, compared to a Non-GAAP operating loss of approximately $9.0 million in 2023, or $0.17 per diluted share.
• Our consolidated combined ratio for the year ended December 31, 2024, was 109.4%, an improvement of 3.3 points from 112.7% in 2023.
• For purposes of our 2024 incentive compensation plan, our Specialty Property Casualty segment recognized an underwriting loss for 2024 of $34.2 million, an improvement of $46.0 million from an underwriting loss of $80.2 million in 2023.
• The MPL line-of-business, within the Specialty P&C segment, recognized an underwriting loss for 2024 of $38.1 million, an improvement of $46.4 million from an underwriting loss of $84.5 million in 2023.
• In our Workers Compensation Insurance segment, we recognized an underwriting loss of $15.9 million in 2024 an improvement of $11.5 million versus $27.4 million the prior year.

Risks

• As an insurance holding company, ProAssurance is subject to insurance laws and regulations in its domiciliary states and states in which it does business.
• State insurance regulatory regimes protect policyholders by vesting in the insurance regulator administrative and supervisory authority to address risks relating to the solvency of insurers and their ability to pay claims as well as to the marketing of insurance products and rates charged for such products.
• The insurance regulations identify key business risks associated with the insurance business and provide guidance as to the management of these risks.
• Many states have adopted laws recommended by the NAIC that require the assessment and reporting of risks associated with current and future business plans for insurers and their holding companies.
• There is a risk that incentive compensation could be paid based on erroneous financial information if our financial statements should be found to be inaccurate in any material respect.

Future Outlook

The Board of Directors expects the strategic plan to improve profitability over time.

Management Comments

• Management has worked very hard in exceptionally challenging market conditions to obtain rate beyond loss cost trends, to use technology to improve efficiency and the customer experience, and to leverage our data science and predictive analytics to enhance risk selection, pricing accuracy, and workflows.
• At the same time, they have focused on streamlining our systems and processes to improve efficiency and reduce costs across the organization, bolstering managements focused effort to return ProAssurance to acceptable levels of profitability.

Industry Context

The document provides insights into the performance and governance of ProAssurance, a corporation operating within the insurance industry, particularly focusing on medical professional liability and workers' compensation. The document highlights the company's strategic initiatives to improve profitability, streamline operations, and leverage technology, which are common themes among insurance companies seeking to enhance their competitive positioning and financial results.

Comparison to Industry Standards

• The document mentions using a peer group of 17 companies for compensation analysis, including Amerisafe, Horace Mann Educators, and RLI, which are publicly held property and casualty specialty insurance organizations.
• The peer group was selected based on total assets, market capitalization, and total revenue, with ProAssurance's metrics falling within the 25th to 75th percentile range of the peer group.
• The document also references the S&P Composite 1500 Property & Casualty Insurance Index for measuring relative stock performance.

Related Party Transactions

• Birmingham Hematology & Oncology Associates, LLC, where Dr. Katisha T. Vance is a physician, partner, and Vice-President, purchased medical professional liability insurance from an insurance subsidiary of ProAssurance in 2022-2024.
• Pacific Inpatient Medical Group, where Dr. Cobarrubias is the Chief Executive Officer, purchased medical professional liability insurance from an insurance subsidiary of ProAssurance in 2022-2024.

Stakeholder Impact

• Stockholders are asked to vote on key proposals, including the election of directors and executive compensation.
• The proposed acquisition by The Doctors Company could significantly impact shareholder value and the future direction of the company.
• Employees are affected by the company's performance and strategic initiatives, as well as executive compensation decisions.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• A separate special meeting will be held to vote on the proposed acquisition of ProAssurance by The Doctors Company.
• The Board of Directors will consider the stockholders' vote on an advisory basis.

Key Dates

Keywords

ProAssurance, stockholders meeting, directors, executive compensation, Ernst & Young, proxy statement, merger agreement, The Doctors Company, insurance, governance